Survival status and risk factors of post-transplantation patients with end-stage liver disease
SHEN Chuan,PENG Cheng-hong,SHEN Bai-yong,YAN Ji-qi,CHEN Hao,XIE Jun-jie,JIN Jia-bin
2012-01-01
Abstract:Objective To analyze the postoperative survival status of liver transplant recipients with end-stage liver disease and to explore the risk factors of long-term survival in liver transplant recipients especially with end-stage liver malignancy. Methods Clinical data of 99 adult patients underwent allogenic liver transplantation with complete follow-up records in Ruijin Hospital, Medical School of Shanghai Jiaotong University from October 2005 to October 2009 were analyzed retrospectively. This study was approved by local ethical committee and the informed consent of all participating subjects was obtained. According to the primary diseases, the patients were divided into the benign group(n=54) and malignancy group (n=45). The 1-, 2-, 3-, 4-year survival rate of recipients were calculated by Kaplan-Meier method and survival curve was drawn and analyzed by Log-rank method. The 12 perioperative variables and 10 variables of liver transplant recipients in the malignancy group were compared by Cox risk regression model to select the risk factors to the recipients' survival. Results Sixty-four cases survived and 35 cases died by October 2009. The 1-, 2-, 3-, 4-year survival rate of recipients were 68%,57%,53% and 53%. The 1-, 2-, 3-, 4-year survival rate in the benign group were 78%, 70%,61% and 61%, while in the malignancy group were 60%, 46%, 46% and 46%. There was no significant difference in the 1-, 2-, 3-, 4-year survival rate between two groups (all in P>0.05). The survival time in the benign group was (35.8±3.0) months while in the malignancy group was (28.7±2.9) months. There was no significant difference between two groups(P>0.05). Cox risk regression analysis showed that the acute physiology and chronic health evaluation (APACHE)Ⅱ scores (odds ratio: 1.21,95% confidence interval:1.05-1.39, P<0.01)of the 12 perioperative variables and the time of anhepatic phase (odds ratio: 2.28,95% confidence interval: 1.26- 4.13, P<0.01) were associated with the postoperative survival time of recipients. The alpha fetal protein (AFP)(odds ratio: 5.94,95% confidence interval: 2.49-14.16,P=0.001) and the tumor microsatellite (odds ratio: 3.40,95% confidence interval: 1.50-7.74, P<0.01) were associated with the postoperative survival time of recipients. Conclusions Preoperative APACHEⅡ scores and the time of intraoperative anhepatic phase are the main risk factors to recipients' survival. Preoperative AFP and tumor microsatellite are the main risk factors that influence the survival time of liver transplant recipients with end-stage liver malignancy.